<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Despite the increase in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> incidence in the last years in Serbia, no nation-wide, population-based <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> epidemiology data have been reported </plain></SENT>
<SENT sid="1" pm="."><plain>In this study <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> incidence and mortality rates for Serbia are presented using nation-wide data from two population-based <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> registries </plain></SENT>
<SENT sid="2" pm="."><plain>These rates are additionally compared to European and global <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> epidemiology estimates </plain></SENT>
<SENT sid="3" pm="."><plain>Finally, predictions on Serbian <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> incidence and mortality rates are provided </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> incidence and mortality was collected from the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> registries of Central Serbia and Vojvodina from 1999 to 2009 </plain></SENT>
<SENT sid="5" pm="."><plain>Using age-specific regression models, we estimated time trends and predictions for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> incidence and mortality for the following five years (2010-2014) </plain></SENT>
<SENT sid="6" pm="."><plain>The comparison of Serbian with European and global <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> incidence/mortality rates, adjusted to the world population (ASR-W) was performed using Serbian population-based data and estimates from GLOBOCAN 2008 </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Increasing trends in both overall <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> incidence and mortality rates were identified for Serbia </plain></SENT>
<SENT sid="8" pm="."><plain>In men, <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> showed the highest incidence (ASR-W 2009: 70.8/100,000), followed by colorectal (ASR-W 2009: 39.9/100,000), prostate (ASR-W 2009: 29.1/100,000) and <z:e sem="disease" ids="C0005684" disease_type="Neoplastic Process" abbrv="">bladder cancer</z:e> (ASR-W 2009: 16.2/100,000) </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0003002'>Breast cancer</z:hpo> was the most common form of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in women (ASR-W 2009: 70.8/100,000) followed by cervical (ASR-W 2009: 25.5/100,000), colorectal (ASR-W 2009: 21.1/100,000) and <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> (ASR-W 2009: 19.4/100,000) </plain></SENT>
<SENT sid="10" pm="."><plain>Prostate and <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> have been significantly increasing over the last years in men, while this was also observed for <z:hpo ids='HP_0003002'>breast cancer</z:hpo> incidence and <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> mortality in women </plain></SENT>
<SENT sid="11" pm="."><plain>In 2008 Serbia had the highest mortality rate from <z:hpo ids='HP_0003002'>breast cancer</z:hpo> (ASR-W 2008: 22.7/100,000), among <z:hpo ids='HP_0000001'>all</z:hpo> European countries while incidence and mortality of cervical, lung and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> were well above European estimates </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSION: <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> incidence and mortality in Serbia has been generally increasing over the past years </plain></SENT>
<SENT sid="13" pm="."><plain>For a number of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> sites, incidence and mortality is alarmingly higher than in the majority of European regions </plain></SENT>
<SENT sid="14" pm="."><plain>For this increasing trend to be controlled, the management of risk factors that are present among the Serbian population is necessary </plain></SENT>
<SENT sid="15" pm="."><plain>Additionally, prevention and early diagnosis are areas where significant improvements could still be made </plain></SENT>
</text></document>